Las Rozas, Spain

Alicia Marcos Llorente

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alicia Marcos Llorente. Retrieved from https://idiyas.com/inventor/alicia-marcos-llorente

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 40.0


Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Las Rozas, ES (2002 - 2003)
  • Madrid, ES (2014)

Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Alicia Marcos Llorente

Introduction

Alicia Marcos Llorente is an accomplished inventor based in Las Rozas, Spain. She is recognized for her significant contributions to the field of medicinal chemistry, particularly through her innovative solutions aimed at addressing various central nervous system disorders. With a total of three patents to her name, Alicia has made a notable impact in the pharmaceutical industry.

Latest Patents

Alicia's most recent patents include groundbreaking compounds designed to selectively target the 5-HT2c receptor. These compounds, specifically formulated as 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines, are developed for the treatment of several disorders associated with the 5-HT2c receptor, such as obesity, obsessive-compulsive disorder, depression, and anxiety. Additionally, she has worked on excitatory amino acid receptor modulators. The compounds she developed are designed to modulate metabotropic glutamate receptor function, offering potential therapeutic benefits for various central nervous system disorders.

Career Highlights

Alicia Marcos Llorente's career is marked by her association with Eli Lilly and Company, a leading global pharmaceutical firm. Her work there has enabled her to leverage advanced research tools and collaborate with like-minded professionals in developing innovative treatments that aim to improve patient care and outcomes.

Collaborations

Collaboration is key to Alicia's success. She has worked closely with colleagues such as Ivan Collado Cano and Concepcion Pedregal Tercero. These partnerships not only enhance her research capabilities but also foster a creative environment conducive to innovation.

Conclusion

Alicia Marcos Llorente exemplifies the spirit of innovation through her dedicated work and impactful patents. Her contributions to the fields of medicinal chemistry and pharmacology continue to pave the way for new treatment options, ultimately benefiting countless patients suffering from complex disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…